Emre M - Search Results

1

Drug profile: transdermal rivastigmine patch in the treatment of Alzheimer disease.

Emre M, Bernabei R, Blesa R, Bullock R, Cunha L, Daniëls H, Dziadulewicz E, Förstl H, Frölich L, Gabryelewicz T, Levin O, Lindesay J, Martínez-Lage P, Monsch A, Tsolaki M, van Laar T. Emre M, et al. CNS Neurosci Ther. 2010 Aug;16(4):246-53. doi: 10.1111/j.1755-5949.2010.00141.x. Epub 2010 Apr 16. CNS Neurosci Ther. 2010. PMID: 20370805 Free PMC article. Review.

2

Strategies for continued successful treatment of Alzheimer's disease: switching cholinesterase inhibitors.

Gauthier S, Emre M, Farlow MR, Bullock R, Grossberg GT, Potkin SG. Gauthier S, et al. Among authors: emre m. Curr Med Res Opin. 2003;19(8):707-14. doi: 10.1185/030079903125002450. Curr Med Res Opin. 2003. PMID: 14687441 Review.

3

Rivastigmine for dementia associated with Parkinson's disease.

Emre M, Aarsland D, Albanese A, Byrne EJ, Deuschl G, De Deyn PP, Durif F, Kulisevsky J, van Laar T, Lees A, Poewe W, Robillard A, Rosa MM, Wolters E, Quarg P, Tekin S, Lane R. Emre M, et al. N Engl J Med. 2004 Dec 9;351(24):2509-18. doi: 10.1056/NEJMoa041470. N Engl J Med. 2004. PMID: 15590953 Free article. Clinical Trial.

4

Rivastigmine in dementia associated with Parkinson's disease and Alzheimer's disease: similarities and differences.

Emre M, Cummings JL, Lane RM. Emre M, et al. J Alzheimers Dis. 2007 Jul;11(4):509-19. doi: 10.3233/jad-2007-11412. J Alzheimers Dis. 2007. PMID: 17656830 Review.

5

Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial.

Emre M, Tsolaki M, Bonuccelli U, Destée A, Tolosa E, Kutzelnigg A, Ceballos-Baumann A, Zdravkovic S, Bladström A, Jones R; 11018 Study Investigators. Emre M, et al. Lancet Neurol. 2010 Oct;9(10):969-77. doi: 10.1016/S1474-4422(10)70194-0. Epub 2010 Aug 20. Lancet Neurol. 2010. PMID: 20729148 Clinical Trial.

6

TREM2 variants in Alzheimer's disease.

Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, Cruchaga C, Sassi C, Kauwe JS, Younkin S, Hazrati L, Collinge J, Pocock J, Lashley T, Williams J, Lambert JC, Amouyel P, Goate A, Rademakers R, Morgan K, Powell J, St George-Hyslop P, Singleton A, Hardy J; Alzheimer Genetic Analysis Group. Guerreiro R, et al. N Engl J Med. 2013 Jan 10;368(2):117-27. doi: 10.1056/NEJMoa1211851. Epub 2012 Nov 14. N Engl J Med. 2013. PMID: 23150934 Free PMC article.

7

Long-term safety of rivastigmine in parkinson disease dementia: an open-label, randomized study.

Emre M, Poewe W, De Deyn PP, Barone P, Kulisevsky J, Pourcher E, van Laar T, Storch A, Micheli F, Burn D, Durif F, Pahwa R, Callegari F, Tenenbaum N, Strohmaier C. Emre M, et al. Clin Neuropharmacol. 2014 Jan-Feb;37(1):9-16. doi: 10.1097/WNF.0000000000000010. Clin Neuropharmacol. 2014. PMID: 24434526 Clinical Trial.

8

Dementia associated with Parkinson's disease.

Emre M. Emre M. Lancet Neurol. 2003 Apr;2(4):229-37. doi: 10.1016/s1474-4422(03)00351-x. Lancet Neurol. 2003. PMID: 12849211 Review.

9

Dementia in Parkinson's disease: cause and treatment.

Emre M. Emre M. Curr Opin Neurol. 2004 Aug;17(4):399-404. doi: 10.1097/01.wco.0000137529.30750.ab. Curr Opin Neurol. 2004. PMID: 15247534 Review.

10

Clozapine treatment in oromandibular dystonia.

Hanagasi HA, Bilgic B, Gurvit H, Emre M. Hanagasi HA, et al. Among authors: emre m. Clin Neuropharmacol. 2004 Mar-Apr;27(2):84-6. doi: 10.1097/00002826-200403000-00007. Clin Neuropharmacol. 2004. PMID: 15252269

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

210 results

Search Page

Filters